
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
Cartilage injuries can turn simple movement into a challenge. Without timely treatment, damage may progress and increase the risk of arthritis or future joint replacement.
At Liquid Cartilage, our goal isjoint preservation and regeneration—not replacement. WithChondroFiller®, we deliver advanced, evidence-led care on Harley Street.

Cartilage provides the smooth, low-friction surface that lets your joints move comfortably. It doesn’t readily self-repair, but with the right scaffold and biological cues,regeneration is possible.
Act early to preserve more of what you have.

ChondroFiller® is an acellular,biologic collagen scaffold delivered in liquid form. Once placed, itgels within minutes, filling the defect and providing a framework that invites your cells to rebuild cartilage.
Think of it like “epoxy” for cartilage—without the plastic.
One treatment. One step. A chance to keep your joint for the long term.


ChondroFiller® sits in a different class—structural regenerative implant.
| Treatment | Analogy | What it Does | Limitation |
|---|---|---|---|
| HA (Hyaluronic Acid) | WD-40 | Improves lubrication for short-term comfort | Temporary; does not regenerate tissue |
| Arthrosamid® | Silicone | Acts on the synovium to reduce pain signalling | Not regenerative; literature notes complication rates up to 30% |
| ChondroFiller® | Epoxy resin | Fills defects, stabilises, and promotes true cartilage repair | Most robust injectable option for structural repair |
ChondroFiller®: our structural, regenerative approach to focal cartilage defects.
Small joints: thumb, fingers, elbow, AC joint, toes, TMJ…
From £2,100
Large joints: knee, hip, shoulder, ankle
From £2,800
Best for knee, hip, shoulder
From £6,500 (knee), £9,500 (hip/shoulder)
Our proprietary MSC Co-Delivery Technique
Introductory offer: your consultation fee is credited toward treatment if you proceed.

Quick, no-obligation chat

Comprehensive assessment with Prof. Paul Lee

Injection, Keyhole, or Liquid Cartilage™

Precise and minimally invasive



Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)
Everything you want to know about ChondroFiller® at Liquid Cartilage.
ChondroFiller® is an acellular collagen gel that fills cartilage defects and forms a scaffold for your own cells to regenerate healthy tissue. Unlike temporary injections, it supports hyaline-like restorationfor smoother motion and protection long-term.
HA or Arthrosamid® may give short-term pain relief, while ChondroFiller® aims to rebuild cartilage. Compared with replacement, it preserves your natural joint and avoids prosthesis risks. Our approach is regenerate-first.
Studies show +30 IKDC in knees,+33 Harris Hip Score in hips, and improved ankle metrics. MRI (MOCART) typically reads 70–87. Globally,>19,000 cases support safety and function.
Best for focal defects up to 6 cm² in knees, hips, ankles, or small joints. Active younger patients often benefit, but older patients may qualify if surrounding cartilage is stable.
Delivered via precise injection orkeyhole surgery. The gel sets in minutes. Expectpartial weight-bearing ~6 weeks, steady return to cycling/swimming, and most sports around~12 months alongside specialist rehab.
Harley Street location; UK ICRS Centre of Excellence. Led byProf. Paul Lee, with advanced options likeLiquid Cartilage™ (ChondroFiller® + cells) to prioritise preservation.
Discover what makes ChondroFiller® unique at Liquid Cartilage.

Cruciate ligament injuries, especially ACL tears, significantly impact mobility and daily life. This article guides patients through surgical options such as autografts, allografts, and minimally invasive arthroscopic procedures, highlighting tailored approaches like single- or double-bundle reconstruction. Surgery is recommended for severe injuries or active lifestyles when conservative treatments fail. Modern techniques prioritize patient safety, precision, and faster recovery. Post-operative rehabilitation including innovative methods like blood flow restriction exercises plays a crucial role in regaining strength and function. Psychological readiness also influences successful return to sport and daily activities. With expert care from specialists and comprehensive assessments, patients can make informed decisions and confidently navigate their treatment and recovery journey.

ChondroFiller represents a pioneering regenerative treatment for cartilage injuries, offering a natural healing approach unlike traditional therapies focusing only on symptom relief. This collagen-based scaffold promotes cartilage cell growth and tissue repair, providing long-term joint recovery. Clinical studies demonstrate ChondroFiller's safety and effectiveness in addressing cartilage defects with improved pain relief and function. Supported by leading experts and integrated with orthopaedic advances like uncemented implants, ChondroFiller signifies a transformative step in joint care. Patients experiencing cartilage damage are encouraged to consult specialists to explore these innovative, personalized treatment options and enhance mobility and quality of life.

Cruciate ligament injuries, particularly anterior cruciate ligament (ACL) tears, are common knee injuries impacting mobility. This guide from Professor Paul Lee and the London Cartilage Clinic details causes, symptoms—such as sudden pain, swelling, and instability—and the importance of early recognition. It highlights injury triggers, including sports and everyday accidents, and discusses diagnostic advances like MRI and computer-aided diagnosis. Treatment varies from conservative care to surgical reconstruction, emphasizing timely expert evaluation for optimal recovery. Learn to identify warning signs and when to seek professional help to protect your knee health effectively.

Explore the latest advancements in non-surgical knee cartilage repair, including physiotherapy, platelet-rich plasma (PRP) injections, and innovative cell therapies. Research highlights promising results from 3D chondrocyte spheroids and nickel-based β-cyclodextrin nanoparticles in promoting cartilage healing. Non-surgical treatments are especially beneficial for mild to moderate damage, offering less risk than surgery. Lifestyle factors like weight management and low-impact exercise further support recovery. Expert care from specialists such as Professor Paul Lee ensures personalized treatment plans tailored to individual needs. While non-surgical options can improve function and reduce pain, ongoing research aims to develop even more effective, minimally invasive therapies. Consult healthcare professionals for personalized guidance in managing knee cartilage damage.

Knee cartilage surgery recovery involves distinct phases: initial pain management and protected movement, followed by progressive rehabilitation focusing on strength and mobility, and long-term gradual return to full activity. Led by expert Professor Paul Lee at the London Cartilage Clinic, personalized rehabilitation plans and ongoing support optimize outcomes. Recovery timelines vary based on individual factors such as age, health, and injury severity. Early physiotherapy, gradual weight-bearing, and tailored exercises are crucial to restore function and prevent setbacks. Patients typically progress from crutches to unassisted walking within weeks and may resume light activities by 3–4 months, while return to high-impact sports can take up to 18 months. Evidence-based guidance ensures safe, effective healing, emphasizing patience and compliance. This comprehensive approach helps patients regain confidence and mobility after knee cartilage surgery.

Cartilage regrowth gels, including hydrogels and cell-free collagen matrices like ChondroFiller, offer promising regenerative treatments for joint cartilage damage. These biocompatible gels support chondrocyte activity to stimulate cartilage repair, potentially reducing pain and improving mobility with less invasive procedures. Early clinical trials in Europe demonstrate positive outcomes, particularly for knee and hip defects, though challenges remain in treatment delivery and long-term efficacy. Despite technical and regulatory limitations, ongoing research aims to enhance these therapies with smart gels and personalized approaches. Patients considering cartilage regrowth gels should seek expert medical advice to weigh benefits against current evidence and practical concerns, as these innovative treatments gradually integrate into standard orthopedic care.